Advertisement
Advertisement

TWST

TWST logo

Twist Bioscience Corporation Common Stock

76.19
USD
Sponsored
+3.86
+5.34%
Jun 04, 13:31 UTC -4
Open

TWST Earnings Reports

Positive Surprise Ratio

TWST beat 18 of 31 last estimates.

58%

Next Report

Date of Next Report
Aug 03, 2026
Estimate for Q3 26 (Revenue/ EPS)
$116.88M
/
-$0.50
Implied change from Q2 26 (Revenue/ EPS)
+5.57%
/
-15.25%
Implied change from Q3 25 (Revenue/ EPS)
+21.68%
/
+6.38%

Twist Bioscience Corporation Common Stock earnings per share and revenue

On May 04, 2026, TWST reported earnings of -0.59 USD per share (EPS) for Q2 26, missing the estimate of -0.48 USD, resulting in a -21.17% surprise. Revenue reached 110.72 million, compared to an expected 109.81 million, with a 0.82% difference. The market reacted with a -6.97% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -0.50 USD, with revenue projected to reach 116.88 million USD, implying an decrease of -15.25% EPS, and increase of 5.57% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Greenwich LifeSciences, Inc.
Report Date
Jun 01, 2026 For Q4 25
Estimate
-$0.32
Actual
-$0.57
Surprise
-77.70%
logo
Connect Biopharma Holdings Limited Ordinary Shares
Report Date
May 22, 2026 For Q1 26
Estimate
-$1.53
Actual
-$2.35
Surprise
-53.05%
FAQ
For Q2 2026, Twist Bioscience Corporation Common Stock reported EPS of -$0.59, missing estimates by -21.17%, and revenue of $110.72M, 0.82% above expectations.
The stock price moved down -6.97%, changed from $60.40 before the earnings release to $56.19 the day after.
The next earning report is scheduled for Aug 03, 2026.
Based on 11 analysts, Twist Bioscience Corporation Common Stock is expected to report EPS of -$0.50 and revenue of $116.88M for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement